Evidence map›Paper›PMID 36404829›Full record

ArticleJournal of diabetes and metabolic disorders2022

Mapping evidence of Iran diabetes research: protocol for a scoping review.

Shahnaz Esmaeili, Fatemeh Bandarian, Farideh Razi, Nazli Namazi, Behnaz Esmaeili, Mahnaz Sanjari, Ali Tootee, Saeedeh Saeedi, Camelia Rambod, Maryam Aalaa and 2 more

Abstract read
In one paragraph

Article in Journal of diabetes and metabolic disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shahnaz EsmaeiliDiabetes Research Center, Endocrinology and Metabolism Clinical sciences Institute, Tehran University of Medical Sciences, PO Box: 1411413137, Tehran, Iran.
Fatemeh BandarianDiabetes Research Center, Endocrinology and Metabolism Clinical sciences Institute, Tehran University of Medical Sciences, PO Box: 1411413137, Tehran, Iran.
Farideh RaziPersonalized medicine research center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Nazli NamaziChronic disease research center. Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Behnaz EsmaeiliImmunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mahnaz SanjariElderly health research center. Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Ali TooteeBiosensor research center. Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Saeedeh SaeediMetabolic Disorders Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Camelia RambodMetabolomics and Genomics Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Maryam AalaaEvidence Based Medicine Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Bagher LarijaniEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical, Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Ensieh Nasli-EsfahaniDiabetes Research Center, Endocrinology and Metabolism Clinical sciences Institute, Tehran University of Medical Sciences, PO Box: 1411413137, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A considerable amount of research funding goes to diabetes management strategies to improve therapeutic goals and reduce the burden of diabetes. A vast amount of the budget is wasted due to unnecessary studies. A scoping review is a pivotal study to overview the available evidence and avoid research waste. In this review, we will try to find out the scope of available studies on diabetes management interventions, identify associated research gaps, and prioritize future studies. Method: We will carry out a study using Arksey and O'Malley's scoping review framework. We will search the Scopus and PubMed databases from 01/01/2015 till 01/01/2020. Only original articles related to pharmacological and non-pharmacological management interventions will be included. These interventional studies should be conducted on the Iranian population. After data extraction, a descriptive data analysis will be used to present information in different charts or tables. We will evaluate related published articles based on their document type, level of evidence, type of diabetes, subject area, interventions types, main findings and outcomes. Discussion: This study represents the first attempt to sum up available studies related to diabetes management interventions performed in Iran. The results of this study will be useful for all the stakeholders and policy-makers involved in diabetes research. It can help clinicians to be informed about studies on management interventions and can guide scientists eager to diabetes research to choose their future research plans based on diabetes research requirements and gaps.

Indexed as

diabetes mellitusdiabetes research mapevidence mappingresearch gapscoping review

Identifiers

PMID36404829
PMCPMC9672267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.